ECHO THERAPEUTICS
Echo Therapeutics is a medical device company with deep expertise in advanced skin permeation technology. Echo is developing its Symphony® CGM System as a non-invasive, wireless, continuous glucose monitoring system for use in hospital critical care units and for people with diabetes. The Prelude® SkinPrep System, a component of their Symphony CGM System, allows for enhanced skin permeation that will enable extraction of analytes, such as glucose, and transdermal drug delivery.
ECHO THERAPEUTICS
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
1989-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.echotx.com
Total Employee:
11+
Status:
Active
Contact:
(215) 717-4100
Email Addresses:
[email protected]
Total Funding:
44.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apache CERTUM
Similar Organizations
Cadent Therapeutics
Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Northwest Biotherapeutics
Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2007-09-17 | Sontra Medical | Sontra Medical acquired by Echo Therapeutics | N/A |
Investors List
Medical Technologies Innovation Asia
Medical Technologies Innovation Asia investment in Post-IPO Equity - Echo Therapeutics
Platinum Partners
Platinum Partners investment in Post-IPO Equity - Echo Therapeutics
Platinum-Montaur Life Sciences
Platinum-Montaur Life Sciences investment in Post-IPO Equity - Echo Therapeutics
Official Site Inspections
http://www.echotx.com Semrush global rank: 8.46 M Semrush visits lastest month: 306
- Host name: 172.67.208.2
- IP address: 172.67.208.2
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Echo Therapeutics"
Echo Therapeutics, Inc. Company Profile - Dun & Bradstreet
Company Description: Echo Therapeutics tries not to scratch the surface. The company develops instruments for transdermal (through the skin) drug delivery and diagnostics. Its devices use …See details»
Echo Therapeutics - Craft
Echo Therapeutics is developing its non-invasive (transdermal & without needles), wireless, continuous glucose monitoring (CGM) system. A significant opportunity exists for the …See details»
Echo Therapeutics - LinkedIn
Echo Therapeutics is developing its non-invasive, wireless, continuous glucose monitoring (CGM) system. A significant opportunity exists for the Company’s CGM to be used in the outpatient ...See details»
Echo Therapeutics - PitchBook
Echo Therapeutics General Information Description. Manufacturer of transdermal skin permeation and diagnostic medical devices intended to serve wearable-health consumer and diabetes outpatient markets.See details»
Sontra Medical and Echo Therapeutics Announce Merger
Sep 17, 2007 Our long-term strategic relationship with Cato Research, a highly-respected global contract research organization, will enable the combined company to maximize the output of …See details»
Echo Therapeutics Company Overview, Contact Details
Feb 8, 2016 [email protected]: 50%. See more formats. Frequently Asked Questions Where is Echo Therapeutics 's headquarters located? Echo Therapeutics 's main headquarters is …See details»
Echo Therapeutics Begins Testing of NextGen CGM System …
ISELIN, N.J., June 29, 2016 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a medical device company focused on non-invasive continuous glucose monitoring (CGM) and …See details»
Echo Therapeutics, Inc. - VentureRadar
Similar Companies: GlySure United Kingdom Privately Held GlySure has developed a continuous intravascular glucose monitoring system using a proprietary optical fluorescence sensor to …See details»
Echo Therapeutics Announces First Quarter 2013 Financial Results
May 10, 2013 In March, Echo was granted International Standards Organization (ISO) 13485:2003 certification of its quality system. ISO 13485:2003 is an internationally recognized …See details»
Begins Testing of NextGen CGM System Components
ISELIN, N.J., June 29, 2016 /PRNewswire/ - Echo Therapeutics, Inc. (Nasdaq: ECTE), a medical device company focused on non-invasive continuous glucose monitoring (CGM) and …See details»
Sontra Medical and Echo Therapeutics Announce Merger
Sep 20, 2007 Founded in 1988 by Dr. Allen Cato and Lynda Sutton and headquartered near Research Triangle Park, NC, Cato Research is a privately held, full-service contract research …See details»
Echo Therapeutics, Inc. Provides Corporate Update and Announces …
ISELIN, N.J., Aug. 14, 2015 /PRNewswire/ -- Echo Therapeutics, Inc. (NASDAQ: ECTE), a medical device company focused on non-invasive continuous glucose monitoring (CGM) and …See details»
Echo Therapeutics in Final Stage of Clinical Research Organization …
ISELIN, N.J., June 2, 2016 /PRNewswire/ -- Echo Therapeutics, Inc. (NASDAQ: ECTE), a medical device company focused on non-invasive continuous glucose monitoring (CGM) and …See details»
Echo Therapeutics to Unveil Non-Invasive Glucose Monitoring …
May 15, 2013 Echo Therapeutics, Inc., a company developing its needle-free Symphony ® CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today …See details»
Echo Therapeutics Announces Positive Clinical Trial Results of …
Aug 1, 2012 "We are extremely pleased with the positive results of this trial which demonstrate that Symphony can accurately read glucose in critically ill patients who have undergone major …See details»
Echo Therapeutics Announces Positive Results of Clinical Trial of its ...
Dec 6, 2011 The feasibility study was designed to evaluate the performance of the Symphony tCGM System in an outpatient setting at a clinical research organization. Twenty (20) adult …See details»
Echo Therapeutics Announces New Website Launch - PR Newswire
ISELIN, N.J., July 1, 2015 /PRNewswire/ -- Echo Therapeutics, Inc. (NASDAQ: ECTE), a medical device company focused on non-invasive continuous glucose monitoring and associated …See details»
Announces Symphony(TM) tCGM System Progress
PHILADELPHIA, May 23, 2011 /PRNewswire/ --Echo Therapeutics, Inc. (OTCBB: ECTE), a company developing the Symphony(TM) tCGM System as a non-invasive, wireless, …See details»
Echo Therapeutics Announces Voting Results of Special Meeting of ...
Apr 14, 2016 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a medical device company focused on non-invasive continuous glucose monitoring (CGM) and associated...See details»